scholarly journals Comparison of expandable hospital competitions in Turkey and USA and space programs

2021 ◽  
Vol 8 (2) ◽  
pp. 22-34
Author(s):  
Tuğşad Tülbentçi ◽  
◽  
Enis Faik Arcan ◽  

The reason behind this article is the idea that “Expandable Hospital Competitions” are significant architectural events due to their organization in two different countries. Additionally, the research topic becomes much important due to the differences in “Hospital Design Standards” arising from the lapse of time as almost half a century since such competitions are organized at different times. The first competition, called “Expandable Hospital,” is organized in Turkey in the year 1975, while the second competition is named “Small Hospital-Big Idea,” which was organized in the USA in the year 2011. Due to such a year gap, the research becomes more multi-dimensional, with significant differences in the competition space programs. At the same time, there have been some improvements socially, general health conditions due to the changes in welfare and communication conditions, etc., hospital organization, medical practices, pharmaceutical manufacturing, medical devices, and medical equipment. All of such factors have changed the space standards that affect the hospital organization in the long year gap. Based on such developments, this study aims to identify the differences between hospital competitions and space programs under the existing conditions through the performance of comparison

2018 ◽  
Vol 22 (1) ◽  
pp. 54-64
Author(s):  
Angela Gazey ◽  
Shannen Vallesi ◽  
Karen Martin ◽  
Craig Cumming ◽  
Lisa Wood

Purpose Co-existing health conditions and frequent hospital usage are pervasive in homeless populations. Without a home to be discharged to, appropriate discharge care and treatment compliance are difficult. The Medical Respite Centre (MRC) model has gained traction in the USA, but other international examples are scant. The purpose of this paper is to address this void, presenting findings from an evaluation of The Cottage, a small short-stay respite facility for people experiencing homelessness attached to an inner-city hospital in Melbourne, Australia. Design/methodology/approach This mixed methods study uses case studies, qualitative interview data and hospital administrative data for clients admitted to The Cottage in 2015. Hospital inpatient admissions and emergency department presentations were compared for the 12-month period pre- and post-The Cottage. Findings Clients had multiple health conditions, often compounded by social isolation and homelessness or precarious housing. Qualitative data and case studies illustrate how The Cottage couples medical care and support in a home-like environment. The average stay was 8.8 days. There was a 7 per cent reduction in the number of unplanned inpatient days in the 12-months post support. Research limitations/implications The paper has some limitations including small sample size, data from one hospital only and lack of information on other services accessed by clients (e.g. housing support) limit attribution of causality. Social implications MRCs provide a safe environment for individuals to recuperate at a much lower cost than inpatient admissions. Originality/value There is limited evidence on the MRC model of care outside of the USA, and the findings demonstrate the benefits of even shorter-term respite post-discharge for people who are homeless.


Author(s):  
Heidi Nicolaisen ◽  
Hanne Cecilie Kavli ◽  
Ragnhild Steen Jensen

The introduction chapter outline the conceptual framework for the volume and describe the current patterns of part-time work. Part-time work has been a much visited research topic and the typical part-time worker still is a woman with children. Although gender and work-life balance continue to be at the heart of this topic, part-time work is increasingly connected to the political and academic debates about labour market outsiders. The ambition of this volume is to provide an up-to-date account of what kind of labour market phenomenon part-time work is to different categories of workers across Europe, the USA, Australia and South Korea and to explore how part-time is linked to precarious work and labour market dualisation. We discuss how the politics, regulations and institutions at different levels (supranational, national and workplace) have the capacity to influence part-time work. Based on the contributions to this book we present a typology of part-time work which moves beyond the traditional insider/outsider divide and provides a more diverse vocabulary for later analysis of part-time work.


2020 ◽  
pp. 75-83
Author(s):  
Svetlana CEBOTARI ◽  
Victoria BEVZIUC

The activity of the World Health Organization is now becoming a topic in disputes between the big power centres – the USA and China. The role of the WHO is also becoming a research topic not only for researchers in medical sciences, but also for political specialists in international relations. With the COVID-19 crisis, the WHO is becoming a scene of the major challenges – the USA and China. This Article aims to highlight the USA and China relations with reference to the work of the WHO, including the effectiveness of the organization with a global pandemic such as that of the COVID-19.


Author(s):  
James Jabara

Manned missions to Mars and other deep space exploration targets are expected to take place in the next 20 years. These missions will involve prolonged crew exposure to the unique space environment, increasing the risk that astronauts will experience additional physical and psychological health conditions beyond those that would be expected through normal aging on Earth. Thus, there is an acute need to develop therapeutic solutions that can withstand the harsh space environment, while maintaining astronaut health and maximizing crew capabilities to foster successful exploration-class missions. This review covers the nuanced and interdisciplinary challenge that is providing safe and effective pharmaceuticals for future deep space missions. First, the limitations of current pharmaceutical solutions are discussed; the impacts of the space environment on human health and chemical compound stability are covered, along with an evaluation of astronaut medication use on similar missions. Second, potential pharmaceutical solutions and concepts are presented for consideration. Future research should prioritize these and other potential innovations to ensure that our space programs are well equipped to maximize crew safety as astronauts explore deep space objectives.


2021 ◽  
Vol 12 (5) ◽  
pp. 15-20
Author(s):  
E. P. Nacharova ◽  
S. M. Kharit ◽  
A. A. Ruleva

The article describes the characteristics and classification of adverse events after immunization (AEFI) according to the latest WHO recommendations. The registration systems for AEFI in the USA and in Russia are described. Particular attention is paid to the interpretation of the convulsive syndrome that developed after vaccination. Four clinical cases of the development of convulsive syndrome in children hospitalized at the Pediatric Research and Clinical Center for Infectious Diseases of Russia (St. Petersburg) in the postvaccination period are presented. The criteria for differential diagnosis of the described diseases are indicated. Only a search for the etiology of the disease allows us to assess the relationship with vaccination, timely conduct adequate therapy and generate objective information on the safety of vaccines. There is a need to register all episodes of seizures after vaccination and introduce new methods for registering PPI, as well as creating a system of statistical accounting of background health conditions (convulsions, allergies) of the population of the Russian Federation of various age groups.


2019 ◽  
Vol 5 (1) ◽  
pp. 605-608
Author(s):  
Marcel Vila Wagner ◽  
Thomas Schanze

AbstractImportant achievements such as the discovery of penicillin increased life expectancy in the 19th century. At the beginning of the 20th century, the influence of technical equipment and biomedical research led to a further leap in life expectancy. The use of computer devices with sophisticated software also improved the quality of life. This is linked to the fact that all these achievements have now led to the emergence of one of the largest import and export markets in the USA, alongside the european union (EU), which is an association of European states. In order to guarantee a uniform quality of this abundance of different products and therapies, there are worldwide corresponding regulations, to which all manufacturers must adhere. The entry into force of these regulations, with the associated approval and testing obligations for each individual medical device, ensures that a consistently high quality of products is used on patients. Of course, high quality as well as high functionality and safety levels of medical products are a must. However, the implementation of these regulations is realized differently in the various markets, as there is no global harmonization. This work focuses on approval procedures for medical devices in Europe (EU) and the USA and compares significant differences in the approval procedures, which are shown as a graphical comparison. An example is an approval of medical devices by the U.S. Food and Drug Administration (FDA), which is an US government agency. In Europe (EU) there is a manufacturer’s declaration of conformity for the approval.


Author(s):  
Manita ◽  
Aakash Deep ◽  
Vikram ◽  
A.C. Rana ◽  
Monu Yadav ◽  
...  

Background: Need for Medical devices is very important in the healthcare sector and related processes for global regulation. Medical devices are the apparatus or instruments which are specifically used for diagnostics and therapeutic applications. In the USA, a regulatory body known as FDA (Food and Drug Administration) has its unit called CDRH which looks the manufacture, packaging and use of medical devices in the USA. Objective: In USA, Medical devices are classified into 3 classes: class I which look for the medical devices used for the general control as dental floss and bandages, etc., class II which regulate the medical devices used for the general control as well as special control as powered wheelchairs and pregnancy kits. Class III medical devices look the general control. PMA (Premarket Approval) and Premarket Notification application has been filed to FDA for seeking the market authorization of medical devices. We perform clinical trials for medical device which are quite different from the clinical trials performed for drug analysis. These trials are performed on various age groups such as on paediatrics, adult and old age group commonly called phase 1,2,3,4. Regulatory approval of high-risk medical device is based on clinical studies submitted with pre-market approval. The main objective of this article is to make the researcher aware of the regulation and clinical trials of medical devices in the USA. Conclusion: Every medical device should comply with FDA, QMS and QSR for marketing in the USA. The present article has focused on the regulation of medical devices, clinical trial phases and clinical studies on medical devices.


2021 ◽  
pp. tobaccocontrol-2020-056090
Author(s):  
Jennifer M Kreslake ◽  
Megan C Diaz ◽  
Muftau Shinaba ◽  
Donna M Vallone ◽  
Elizabeth C Hair

ObjectiveTo determine whether awareness of emerging vaping-attributable health conditions influences vaping-related risk perceptions and behaviours among young people.DesignRespondents aged 15–24 years (n=3536) were drawn from a repeated cross-sectional online panel survey (222 participants/week) during an e-cigarette/vaping-associated lung injury (EVALI) outbreak in the USA (September 2019–January 2020). Logistic regression models tested for associations between EVALI awareness and perceived lung injury risk and product harm, stratified by e-cigarette/vape use and controlling for awareness of other e-cigarette/vaping news stories, demographic characteristics and outbreak week. Other models measured the association between perceived risk of lung injury and intentions to use (non-users) or intentions to quit (current users) e-cigarettes/vape products. Changes in national retail e-cigarette sales data were examined during national EVALI outbreak reporting.ResultsEVALI awareness was associated with: perceived risk of lung injury (current users OR 1.59, p=0.004; non-users OR 2.11, p<0.001); belief that e-cigarettes/vapes contain dangerous chemicals (current users OR 1.47, p=0.017; non-users OR 1.88, p<0.001) and belief that e-cigarettes/vapes are harmful (current users OR 1.66, p=0.002; non-users OR 1.67, p<0.001). Perceived risk of lung injury from e-cigarette/vape use was associated with intentions to own e-cigarette/vape products (ever-users OR 0.25, p<0.001; never-users OR 0.61, p=0.004) and intentions to quit among current users (OR 2.02, p=0.002). Declines in e-cigarette sales were observed following news of the EVALI outbreak.ConclusionsNews of vaping-attributable health conditions may prevent e-cigarette/vape use and encourage cessation among young people. Tobacco control campaigns should address uncertain health effects of e-cigarettes or vape products and align with risk communication by public health agencies during outbreaks.


Sign in / Sign up

Export Citation Format

Share Document